18.56k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
---|---|---|---|---|
The Fight Against COVID19 | +5.36% | - | - | - |
^GSPC | -1.45% | +1.56% | +15.79% | +3979.23% |
Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 168.6901 | -1.79 | -1.05% | 1:18 p.m. EST | 6.45M | 7.73M | 444.08B |
PFE | Pfizer Inc. | 36.4 | -0.91 | -2.44% | 1:18 p.m. EST | 25.18M | 46.96M | 202.33B |
ABBV | AbbVie Inc. | 103.93 | -4.87 | -4.48% | 1:18 p.m. EST | 6.42M | 8.20M | 183.49B |
SNY | Sanofi | 47.94 | -1.21 | -2.46% | 1:17 p.m. EST | 1.20M | 1.93M | 120.65B |
GSK | GlaxoSmithKline plc | 38.57 | -0.67 | -1.71% | 1:17 p.m. EST | 2.38M | 4.93M | 95.86B |
GILD | Gilead Sciences, Inc. | 66.065 | -0.63 | -0.95% | 1:18 p.m. EST | 5.00M | 9.38M | 82.81B |
MRNA | Moderna, Inc. | 163.36 | +11.43 | +7.52% | 1:18 p.m. EST | 12.76M | 23.97M | 64.64B |
REGN | Regeneron Pharmaceuticals, Inc. | 519.025 | -25.07 | -4.61% | 1:18 p.m. EST | 858.08k | 934.88k | 55.38B |
TAK | Takeda Pharmaceutical Company Limited | 17.59 | -0.59 | -3.25% | 1:18 p.m. EST | 5.30M | 2.50M | 55.13B |
BNTX | BioNTech SE | 109.62 | +3.33 | +3.13% | 1:18 p.m. EST | 1.53M | 4.09M | 26.39B |
VIR | Vir Biotechnology, Inc. | 109.02 | +31.64 | +40.89% | 1:18 p.m. EST | 9.56M | 1.19M | 13.89B |
NVAX | Novavax, Inc. | 131.12 | +3.96 | +3.11% | 1:18 p.m. EST | 2.07M | 4.12M | 8.82B |
INO | Inovio Pharmaceuticals, Inc. | 13.045 | +2.47 | +23.30% | 1:18 p.m. EST | 29.82M | 11.54M | 2.67B |
President Joe Biden announced changes to the country's vaccine supply and distribution plans.
Dr. William Yates, Former Trauma Surgeon and Founder of Yates Protect Infrared Thermal Detection, joins Yahoo Finance's Kristin Myers to break down the latest coronavirus developments.
Johnson and Johnson expects vaccine data next week.